Detail page

Knowledge Web

Person

Ingo Müller (1969-)

Kinderarzt

Name	Ingo Müller
Time	1969- (Date of birth and death)
Place	Schwalmstadt-Ziegenhain (Geburtsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med. Dipl.-Biochem.
Profession	Kinderarzt (characteristic profession) Arzt Biochemiker Hochschullehrer
Variant	I. Müller
Related	Universitätsklinikum Hamburg-Eppendorf Universitätsklinik für Kinder- und Jugendmedizin Tübingen
Further information	Habil. Fachgebiet Kinder- und Jugendmedizin an der Univ. Tübingen; Leiter Pädiatrische Stammzelltransplantation, Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie
Source	https://fis-uke.de/portal/de/persons/ingo-muller(0291c259-8783-4937-bbf3-42260802e269).html (Stand: 24.01.2023) https://www.uke.de/allgemein/arztprofile-und-wissenschaftlerprofile/arztprofilseite_ingo_m%C3%BCller.html (Stand: 24.01.2023)
Record type	Person
GND-Identifier	118162152
Record ID	118162152
Involved in show all Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial Bedeutung des Gehaltes an kernhaltigen, CD34+- und CD3+-Zellen im Transplantat für das Therapieergebnis bei Patienten nach allogener hämatopoetischer Stammzelltransplantation von einem Fremdspender im Kindes- und Jugendalter Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial Antineoplastische Wirkung von PARP-Inhibitoren in Kombination mit ATR- oder ATM-Inhibitoren auf Ewing-Sarkomzellen Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome Modulation of human leukocyte antigen class I molecules with low surface densitiy by human immunodeficiency virus type 1 : implications for NK cell effector function Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy Wirkung des HSP90-Inhibitors AUY922 in Ewing-Sarkomzellen Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL Histon-Lysin-Demethylase 1A (KDM1A)-unabhängige Wirkung des KDM1A- Inhibitors SP2509 auf akute myeloische Leukämie-, Ewing-Sarkom- und Prostatakarzinomzellen Adenovirusinfektionen nach hämatopoetischer Stammzelltransplantation im Kindesalter Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation Bedeutung der WT1-Genexpression als molekularer Marker residueller Leukämiezellen vor und nach hämatopoetischer Stammzelltransplantation im Kindesalter Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia Herstellung und Untersuchungen von mesenchymalen Stromazellpräparaten unter GMP-nahen Bedingungen zum Einsatz bei Patienten nach hämatopoetischer Stammzelltransplantation Wirksamkeit und Verträglichkeit von Posaconazol in der Prophylaxe und Therapie invasiver Pilzerkrankungen in der pädiatrischen Onkologie und hämatopoetischen Stammzelltransplantation Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation Mesenchymal stromal cells for treatment of steroid-refractory GvHD : a review of the literature and two pediatric cases Mesenchymale Stammzellen : Von der Biologie zum klinischen Einsatz Immunologische und zellbiologische Aspekte multipotenter mesenchymaler Stromazellen im Rahmen der Stammzelltransplantation und regenerativen Medizin Haploidentical Stem Cell Transplantation in Patients with Pediatric Solid Tumors: Preliminary Results of a Pilot Study and Analysis of Graft versus Tumor Effects A Comparison between Three Graft Manipulation Methods for Haploidentical Stem Cell Transplantation in Pediatric Patients: Preliminary Results of a Pilot Study Biochemische Analyse von p120/130 : ein Zielprotein der T-Zellrezeptor-assoziierten Tyrosinkinase p59fyn

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Ingo Müller (1969-)

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity

Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Bedeutung des Gehaltes an kernhaltigen, CD34+- und CD3+-Zellen im Transplantat für das Therapieergebnis bei Patienten nach allogener hämatopoetischer Stammzelltransplantation von einem Fremdspender im Kindes- und Jugendalter

Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Antineoplastische Wirkung von PARP-Inhibitoren in Kombination mit ATR- oder ATM-Inhibitoren auf Ewing-Sarkomzellen

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Modulation of human leukocyte antigen class I molecules with low surface densitiy by human immunodeficiency virus type 1 : implications for NK cell effector function

Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy

Wirkung des HSP90-Inhibitors AUY922 in Ewing-Sarkomzellen

Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature

Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature

Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL

Histon-Lysin-Demethylase 1A (KDM1A)-unabhängige Wirkung des KDM1A- Inhibitors SP2509 auf akute myeloische Leukämie-, Ewing-Sarkom- und Prostatakarzinomzellen

Adenovirusinfektionen nach hämatopoetischer Stammzelltransplantation im Kindesalter

Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation

Bedeutung der WT1-Genexpression als molekularer Marker residueller Leukämiezellen vor und nach hämatopoetischer Stammzelltransplantation im Kindesalter

Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation

Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia

Herstellung und Untersuchungen von mesenchymalen Stromazellpräparaten unter GMP-nahen Bedingungen zum Einsatz bei Patienten nach hämatopoetischer Stammzelltransplantation

Wirksamkeit und Verträglichkeit von Posaconazol in der Prophylaxe und Therapie invasiver Pilzerkrankungen in der pädiatrischen Onkologie und hämatopoetischen Stammzelltransplantation

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Mesenchymal stromal cells for treatment of steroid-refractory GvHD : a review of the literature and two pediatric cases

Mesenchymale Stammzellen : Von der Biologie zum klinischen Einsatz

Immunologische und zellbiologische Aspekte multipotenter mesenchymaler Stromazellen im Rahmen der Stammzelltransplantation und regenerativen Medizin

Haploidentical Stem Cell Transplantation in Patients with Pediatric Solid Tumors: Preliminary Results of a Pilot Study and Analysis of Graft versus Tumor Effects

A Comparison between Three Graft Manipulation Methods for Haploidentical Stem Cell Transplantation in Pediatric Patients: Preliminary Results of a Pilot Study

Biochemische Analyse von p120/130 : ein Zielprotein der T-Zellrezeptor-assoziierten Tyrosinkinase p59fyn